Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Exact Sciences Corp. (NASDAQ: EXAS) closed at $49.40 in the last session, up 2.56% from day before closing price of $48.17. In other words, the price has increased by $2.56 from its previous closing price. On the day, 2.43 million shares were traded. EXAS stock price reached its highest trading level at $50.08 during the session, while it also had its lowest trading level at $47.31.
Ratios:
We take a closer look at EXAS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.45 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on June 27, 2024, initiated with a Sector Outperform rating and assigned the stock a target price of $70.
The Benchmark Company Upgraded its Hold to Buy on January 02, 2024, while the target price for the stock was maintained at $91.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 01 ’24 when Conroy Kevin T sold 1,155 shares for $60.15 per share. The transaction valued at 69,473 led to the insider holds 1,156,191 shares of the business.
Cunningham Everett sold 136 shares of EXAS for $8,180 on May 01 ’24. The Chief Commercial Officer now owns 47,042 shares after completing the transaction at $60.15 per share. On May 01 ’24, another insider, Elliott Jeffrey Thomas, who serves as the Chief Financial Officer of the company, sold 136 shares for $60.15 each. As a result, the insider received 8,180 and left with 11,795 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 9115782144 and an Enterprise Value of 11038419968. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.60 while its Price-to-Book (P/B) ratio in mrq is 2.90. Its current Enterprise Value per Revenue stands at 4.355 whereas that against EBITDA is -101.79.
Stock Price History:
The Beta on a monthly basis for EXAS is 1.23, which has changed by -0.4851485 over the last 52 weeks, in comparison to a change of 0.21656322 over the same period for the S&P500. Over the past 52 weeks, EXAS has reached a high of $99.56, while it has fallen to a 52-week low of $40.62. The 50-Day Moving Average of the stock is 6.25%, while the 200-Day Moving Average is calculated to be -17.74%.
Shares Statistics:
According to the various share statistics, EXAS traded on average about 3.03M shares per day over the past 3-months and 2467880 shares per day over the past 10 days. A total of 184.53M shares are outstanding, with a floating share count of 182.22M. Insiders hold about 1.25% of the company’s shares, while institutions hold 89.02% stake in the company. Shares short for EXAS as of 1719532800 were 14212881 with a Short Ratio of 4.69, compared to 1717113600 on 8781575. Therefore, it implies a Short% of Shares Outstanding of 14212881 and a Short% of Float of 7.7800006.
